Novo Nordisk Production Belgium Sa
Novo Nordisk Production Belgium Sa is a Public Limited Company registered in Belgium under 0465935738, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 22 April 1999 and lists its registered address as Belgium. 1 shareholder is on record for Novo Nordisk Production Belgium Sa, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Novo Nordisk Production Belgium Sa
One shareholder is currently on record for Novo Nordisk Production Belgium Sa, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Novo Nordisk Belgium Manufacturing Holding S, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Novo Nordisk Belgium Manufacturing Holding S | 100% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
Directors and officers of Novo Nordisk Production Belgium Sa
Four of the 5 officer records shown for Novo Nordisk Production Belgium Sa are current appointments, filed with Crossroads Bank for Enterprises (KBO/BCE). Eric Van Hoof, Stéphane Vangertruyden, Eric Kummer and ADAM LAWRENCE all serve as Director. The remaining 1 record shown (Geoffroy Beckers) is a former appointment that has since been resigned. Management authority at Novo Nordisk Production Belgium Sa sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 27 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Novo Nordisk Production Belgium Sa
Novo Nordisk Production Belgium Sa sits 7 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark. The full chain up to Novo Nordisk Fonden is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Novo Nordisk Production Belgium Sa's own shareholder record.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Novo Nordisk Fonden
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Novo Nordisk Production Belgium Sa?
One shareholder is currently on record for Novo Nordisk Production Belgium Sa, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Novo Nordisk Belgium Manufacturing Holding S, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Novo Nordisk Production Belgium Sa's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Novo Nordisk Production Belgium Sa is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Novo Nordisk Production Belgium Sa have on record?
1 shareholder is shown on record for Novo Nordisk Production Belgium Sa.
What is Novo Nordisk Production Belgium Sa's company registration number?
Novo Nordisk Production Belgium Sa's registration number is 0465935738, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Novo Nordisk Production Belgium Sa still an active company?
Novo Nordisk Production Belgium Sa's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Novo Nordisk Production Belgium Sa incorporated?
Novo Nordisk Production Belgium Sa was incorporated on 22 April 1999, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Novo Nordisk Production Belgium Sa's registered address?
The registered address on file for Novo Nordisk Production Belgium Sa is Belgium.
What legal structure is Novo Nordisk Production Belgium Sa registered as?
Novo Nordisk Production Belgium Sa is registered as a Public Limited Company in Belgium.
Who are the officers/directors of Novo Nordisk Production Belgium Sa?
Four of the 5 officer records shown for Novo Nordisk Production Belgium Sa are current appointments, filed with Crossroads Bank for Enterprises (KBO/BCE). Eric Van Hoof, Stéphane Vangertruyden, Eric Kummer and ADAM LAWRENCE all serve as Director. The remaining 1 record shown (Geoffroy Beckers) is a former appointment that has since been resigned. Management authority at Novo Nordisk Production Belgium Sa sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Novo Nordisk Production Belgium Sa have a parent company or subsidiaries?
Novo Nordisk Production Belgium Sa sits 7 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark.
Can Zavia monitor changes to Novo Nordisk Production Belgium Sa's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Novo Nordisk Production Belgium Sa's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Novo Nordisk Production Belgium Sa's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Novo Nordisk Production Belgium Sa's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 28 September 2026.